Alliance to Develop Molecular Imaging Techniques

A collaboration to undertake development of molecular imaging techniques for use in ultrasound, magnetic resonance, and nuclear medicine has been announced by Philips Medical Systems (Best, The Netherlands) and Kereos (St.Louis, MO, USA).

The collaboration will focus on image-based characterization of the molecular causes of diseases and will combine Kereos' targeted nanoparticle technology with Philips' engineering, software development, and equipment support. The goal is to facilitate development of molecular imaging agents for specific and sensitive detection of tumors and vulnerable plaque in arteries, a major cause of heart disease. The leader of the project is Dr. Samuel A. Wickline, M.D., professor of medicine, biomedical engineering, and physics at Washington University School of Medicine in St. Louis (MO, USA).

"Our team is very excited about this agreement,” said Dr. Wickline. "We are certain that it will quickly lead to major breakthroughs in advancing contrast agent and scanner technology for molecular imaging and targeted therapeutics.”





Related Links:
Philips Medical Systems
Kereos